The Moraxella immunoglobulin (Ig) D-binding protein (MID) induces a strong proliferative response in human peripheral blood IgD þ B cells from adults isolated by positive selection using anti-CD19-conjugated microbeads. Here, we show that tonsillar B cells from children isolated with positive selection are unable to respond to MID stimulation. The proliferative response was very low or absent at various concentrations of MID tested and at different time points analysed, whereas the MID response of tonsillar B cells from adults isolated with positive selection was considerably higher. Tonsillar B cells from children isolated with positive selection responded to formalin-fixed preparations of Moraxella catarrhalis and Staphylococcus aureus Cowan strain I. In comparison to cells isolated with positive selection, a much higher proliferative response was recorded in tonsillar B cells from children isolated with negative selection, indicating that occupation of the CD19 molecule (i.e. positive selection) inhibited the response. Indeed, the addition of anti-CD19 monoclonal antibodies (MoAb) to MID-activated tonsillar B cells from children isolated with negative selection strongly inhibited the proliferative response. In contrast, anti-CD21 MoAb at the same concentration did only show a minor inhibition on the MID-induced response. Pre-incubation of tonsillar B cells isolated from children with anti-CD19 or anti-CD21 MoAb did not affect the binding of biotin-conjugated MID as analysed by flow cytometry. These results suggest that MID-activated tonsillar B cells from children have a strong requirement for signalling through the CD19 molecule. Future experiments will further reveal the importance of CD19 and possibly other molecules for optimal activation of tonsillar B cells isolated from both children and adults.
Introduction
The B-cell receptor (BCR) on naïve B cells is of low affinity because the antigen receptors are unmutated [1] . The BCR is linked to CD21 (complement receptor 2 or CR2) which in turn is in complex with CD19/TAPA-1/ Leu-13. This complex is capable of lowering the threshold for activation through the BCR. CD21 and CD19 interact through extracellular and transmembrane regions [2] . CD19 is a B-cell-specific member of the immunoglobulin (Ig) superfamily expressed by pre-B cells from the time of heavy-chain rearrangement until plasma cell differentiation [3] . CD19 has no known ligand but mediates intracellular signalling after cross-linking with CD21 and the BCR [4] . Antigen-bound C3d, the final cleavage product of C3, cross-links CD21 to the BCR and enhances signalling through the antigen receptor by one to two orders of magnitude [5] . Moreover, cross-linking either CD19 or CD21 to limited numbers of membrane IgM on B cells enhances by 10-1000-fold the cellular responses, elevation of intracellular Ca 2þ , activation of mitogen-activated protein (MAP) kinases and proliferation [6] .
The signals through the B-cell antigen receptor are central to B-cell development and antigen response. Defective BCR signalling can result in impaired B-cell development, immunodeficiencies and predisposition of autoimmunity [7] . The mature, naïve B cell expresses both IgM and IgD molecules on its surface, which acts as the B-cell receptor for the antigen. IgD may play a critical role in humoral defence against pathogens undergoing rapid expansion and mutational drift upon entry in the host [8] . This is supported by the delayed antibody production and affinity maturation in response to model T-cell-dependent antigens of IgD-deficient mice. IgDsecreting plasma cells are very sparse in the bone marrow, but numerous in nasal mucosa, adenoids, salivary and lachrymal glands and infected tonsils [9] . Interestingly, as much as 20% of tonsil plasma cells have been reported to produce IgD [10, 11] . The tonsils are lymphoid tissues located in the pharynx that play an important role in the host defence against invading antigens in the upper respiratory tract. Several studies have demonstrated that the adenoids and the tonsils are engaged in antibody responses to bacterial pathogens that have a tropism to the naso-or oropharynx, like Streptococcus pneumoniae, Haemophilus influenzae and b-haemolytic streptococci [12, 13] . The anatomical localization and histological organization of the tonsils are particularly suited for the capture of foreign material from epithelial surfaces. Moraxella catarrhalis is a pathogen involved in respiratory tract infections in both children and adults [14, 15] . S. pneumoniae, H. influenzae and M. catarrhalis are all able to cause acute otitis media in children. Interestingly, both H. influenzae and M. catarrhalis express outer membrane surface proteins that activate IgD þ B lymphocytes by cross-linking IgD [16] [17] [18] . In fact, M. catarrhalis was already shown to display a strong affinity for soluble human IgD two decades ago [16] .
A novel surface protein of M. catarrhalis designated MID for Moraxella IgD-binding protein was recently isolated in our laboratory [19] . The protein of approximately 200 kDa was found to bind to two purified IgD myeloma proteins, four IgD myeloma sera and one IgD standard serum. No binding of MID to IgG, IgM, IgA or IgE was detected [19] . Moreover, MID induced a strong proliferative response in human peripheral IgD þ B lymphocytes [20] . The binding and subsequent activation of MID was IgD specific, and MID did neither bind to nor activate T cells or monocytes from human peripheral blood. IgM secretion was detected in B cells stimulated with MID and interleukin (IL)-2, whereas the secretion of IgG and IgA was induced by MID, IL-4, IL-10 and soluble CD40L. A truncated fragment of MID comprising 238 amino acid residues has been identified with preserved IgD binding (MID 962À1200 ) [21] . Interestingly, the IgD-binding capacity of a tetrameric structure of MID 962À1200 was 20-fold more efficient than the monomeric form, indicating that optimal binding of MID to IgD requires a tetramer.
In the present study, we have analysed the MID response of tonsillar B cells isolated from children and adults. Tonsillar B cells isolated from children with anti-CD19 monoclonal antibodies (MoAb) (positive selection) were unable to respond to IgD-mediated MID stimulation. In contrast, B cells from most adult donors isolated with positive selection responded to MID stimulation by proliferation. Most interestingly, tonsillar B cells from children isolated with negative selection could be induced to a strong proliferation in the presence of MID. Moreover, the proliferative response of MID-activated tonsillar B cells isolated from children with negative selection was inhibited in the presence of anti-CD19 MoAb, but not to the same extent by anti-CD21 MoAb. These results indicate that the CD19 molecule, either alone or in complex with CD21, is necessary for optimal MID activation through IgD and that tonsillar B cells from children have a stronger requirement compared to adults for costimulation through the CD19 molecule.
Materials and methods
Reagents. The purification of the M. catarrhalis outer membrane protein MID has been described previously [19] . Formalin-fixed preparations of M. catarrhalis strain Bc5 and Staphylococcus aureus strain Cowan I were titrated for optimal stimulation of tonsillar B lymphocytes. MoAb to the following antigens were used: mouse anti-human leucocyte antigen-DR (HLA-DR)-fluorescein isothiocyanate (FITC) and CD3-R-phycoerythrin (RPE) (Immunotech, Marseille, France), rabbit anti-human IgD-RPE, mouse-anti-human CD21, rabbit antimouse-FITC, rabbit anti-human CD19-FITC, rabbit anti-human CD19-RPE, streptavidin-RPE and rabbit-anti-human IgD-RPE from DAKO (Glostrup, Denmark). Mouse anti-human CD19 was from Serotec (Oxford, UK).
Biotinylation of MID. MID was conjugated with biotin using a FluoReporter 1 Mini-Biotin-XX protein-labelling kit (Molecular Probes, Oregon, OR, USA) according to the manufacturer's instructions. For the analysis of MID binding to membrane IgD on B cells, 20 mg/ml of MIDbiotin was incubated with 4 Â 10 5 tonsillar B cells for 20 min on ice. The cells were washed twice with 0.5% phosphate-buffered saline (PBS)-bovine serum albumin (BSA) and thereafter incubated for 20 min with streptavidin-RPE as a secondary step. After two washes in 0.5% PBS-BSA, the binding of MID-biotin to tonsillar B cells was analysed by flow cytometry (FACSCalibur, BD Biosciences, San Jose, CA, USA). When studying potential disturbance by anti-CD19 and anti-CD21 antibodies on MID binding to B cells, cells were first pre-incubated with the antibodies for 30 min on ice and thereafter washed twice in 0.5% PBS-BSA before incubating with MIDbiotin as described above.
Cell preparations. Human tonsils were obtained from children (age 2-6 years) and adults (age >18 years) undergoing tonsillectomy at Malmö University Hospital (Ethical approvement No. LU 486-01). Briefly, tonsils were minced and cell suspension filtered through 70 mm nylon cell strainer (Becton Dickinson, Lincoln Park, NJ, USA) before Lymphoprep (Nycomed, Oslo, Norway) densitygradient centrifugation. B lymphocytes were isolated either by positive selection using anti-CD19-conjugated magnetic beads or by negative selection using human B cell isolation kit II and thereafter anti-CD3-conjugated magnetic beads (Miltenyi Biotec, Bergisch Gladbach, Germany). A VarioMACS magnetic cell sorter (Miltenyi Biotec) was used for B-cell isolation according to the manufacturer's instructions. The positively selected B cells were routinely >97% HLA-DR þ . Negative selection of B cells allows a purification protocol without the addition of B-cell-specific MoAb. However, the final purity of negatively selected B cells is usually lower than 90% as measured by the number of HLA-DR þ and CD3 þ T cells. To achieve higher than 97% purity of negatively selected B cells, we performed negative selection of B cells and thereafter anti-CD3-positive selection of the remaining T cells. The purity of the final negatively selected B-cell population was routinely >97% HLA-DR þ . B cells (2 Â 10 5) from human tonsils were incubated in RPMI-1640 medium (Life Technologies, Paisley, UK) supplemented with 10% fetal calf serum, 50 mg/ml gentamicin and 200 U/ml penicillin (culture medium) and cultured in 96-well round-bottom plates (Nunc, Roskilde, Denmark) in triplicates in a final volume of 200 ml culture medium. Cell proliferation was measured routinely after 3 days (or as indicated) by [methyl-3 H]thymidine incorporation (5 mCi/well; Amersham Biosciences, Piscataway, NJ, USA) using an 18 h pulse period.
Detection of IL-6 by enzyme-linked immunosorbent assay (ELISA). IL-6 production was measured from cell supernatants harvested on day 3. In brief, ELISA plates (Maxisorp, Nunc) were coated with 50 ml of a solution containing rat anti-IL-6 antibody (2 mg/ml; Pharmingen, San Diego, CA, USA) diluted 1/1500 in 0.1 M Na 2 HPO 4 , pH 9.0. Standards and supernatants were diluted in PBS/ Tween-20 (0.05%). Biotinylated rat anti-IL-6 antibody (1 mg/ml; BD PharMingen) was used as the secondary antibody, and thereafter HRP-conjugated avidin was added. Tetramethylbenzidine and hydrogen peroxide were used as chromogen and substrate. Finally, the absorbance at 405 nm was determined.
Statistic. A one-tailed t-test was used to determine the P-values.
Results and discussion
The IgD-mediated response of MID-stimulated tonsillar B cells from children isolated by positive selection using anti-CD 19-conjugated beads is very low or absent
We have recently shown that the novel outer membrane protein MID displays IgD-binding properties and is stimulatory for human IgD þ peripheral blood B cells [20] . To optimize the response, soluble costimulatory molecules such as IL-4 and CD40 ligand (CD40L) was added to MID-stimulated peripheral blood B cells. In the present study, tonsillar B cells from children and adults were isolated either by positive selection using anti-CD19-conjugated magnetic beads or by negative selection. The purified B cells were thereafter subjected to stimulation with various concentrations of MID. The children analysed in this study were aged between 2 and 6 years and the adults were 18 years or older.
Tonsillar B cells from both children and adults were subjected to purification by positive selection using anti-CD19 beads. The concentration of MID that induced a maximal response in IgD þ peripheral blood B cells [20] and in tonsillar B cells isolated from adults was 0.5 mg/ml, whereas a much lower response was seen in tonsillar B cells isolated from children when stimulated with the same concentration of MID (Fig. 1A-C) . As shown in Fig. 1A , the proliferative response of tonsillar B cells isolated from children was very low or absent at all concentrations of MID tested, whereas the response of tonsillar B cells isolated from adults was high and comparable to that seen in IgD þ peripheral blood B cells [20] . In total, tonsillar B cells from 14 children and 18 adults were isolated and purified by positive selection and thereafter activated with 0.5 mg/ml of MID. The proliferative response of adult tonsillar B cells was significantly higher compared to the response of B cells isolated from children (Fig. 1B) . A sixfold increase was detected in the proliferative response and the IL-6 production of MID-stimulated tonsillar B cells isolated from adults compared to children (Fig. 1B,C) . Interestingly, B cells isolated from children with positive selection using anti-CD19 beads responded to a formalin-fixed preparation of M. catarrhalis (MCat) (Fig. 1D) and to a formalin-fixed preparation of S. aureus Cowan strain I (S. aur.) (Fig. 1E) . However, the response in B cells isolated from adults was significantly higher.
The absence of the IgD-mediated MID response in tonsillar B cells from children purified by anti-CD19-conjugated beads is not due to a different kinetics B cells purified by positive selection from children and adults were stimulated with 0.5 mg/ml of MID and incubated during different time points as indicated (Fig. 2) . The result shows that MID induced a very weak response in tonsillar B cells isolated from children and purified by positive selection at all time points analysed, whereas the response of tonsillar B cells isolated from adults was high.
Isolation of tonsillar B cells from children by negative selection results in a strong IgD-mediated proliferative response Tonsillar lymphocytes isolated from three children were split in half before purification and purified either by positive selection using anti-CD19-conjugated beads or negative selection. The proliferative response of MID-stimulated tonsillar B cells isolated with positive selection was low (Fig. 3A) , whereas the response in tonsillar B cells isolated with negative selection was considerably higher (Fig. 3B) . These results indicate that occupation of the CD19 molecule (i.e. positive selection) inhibits IgDmediated stimulation. The proliferative response induced by MCat, a formalin-fixed preparation of M. catarrhalis, was also higher in tonsillar B cells from children after isolation with negative selection (Fig. 3B) . The response induced by S. aureus, a formalin-fixed preparation of Staphylococcus aureus Cowan strain I, was high in B cells isolated with positive selection, but increased further in B cells isolated by negative selection. Indeed, several studies have shown that IgM stimulation is enhanced by costimulation through CD19 [3, 5] . To our knowledge, this is the first time it is shown that CD19 is an important coreceptor for IgD-mediated stimulation. Hadzic et al.  .............................................................................................................................................................................................. 
....
Blocking experiments with anti-CD19 antibody reveal the importance of this costimulatory molecule for optimal MID activation of tonsillar B cells from children CD19 is physically associated with CD21 in the cell membrane. After positive selection of B cells using anti-CD19-conjugated beads, not only the CD19 molecule but also the CD21 molecule is occupied for anti-CD21 MoAb staining (our own observation). We therefore aimed to block the MID-induced proliferation of negatively selected B cells by adding either anti-CD19 or anti-CD21 MoAb to the culture. Indeed, the addition of anti-CD19 MoAb strongly inhibited the proliferation of MID-activated B cells from children (Fig. 4) . The addition of anti-CD21 MoAb only had a minor inhibitory effect on the MIDinduced proliferation of B cells in children (Fig. 4) . Similar results were obtained in adults when blocking with anti-CD19 antibody, indicating the importance of this molecule in older age groups as well (data not shown).
Here, we demonstrate that protein MID and MCat are unable to induce an optimal response in IgD þ tonsillar B cells from children isolated by positive selection using anti-CD19-conjugated beads. In contrast, tonsillar B cells from the same donors isolated with negative selection show a 10-to 20-fold increase in the response to MID and MCat. Our results suggest that the CD19 molecule is crucial for the IgD-binding protein MID to stimulate B cells. MID-induced proliferation and IL-6 production are totally inhibited in tonsillar B cells isolated from most children when the CD19 molecule is physically blocked. This is true when using positive selection with anti-CD19-conjugated beads as the purification method as well as when adding anti-CD19 MoAb in culture to MID-activated B cells isolated with negative selection. Interestingly, blocking with anti-CD21 MoAb did not have such dramatic effect (Fig. 4) . As CD21 has a very short cytoplasmic domain without signalling function, CD21 most likely serves as a ligand-binding subunit that links the recognition of antigen to the signalling function of CD19 [6] .
Anti-CD19 or anti-CD21 MoAb do not block IgD targeting of protein MID
We next evaluated whether the binding of MID to IgD was affected by pre-incubation of anti-CD19 or anti-CD21 MoAb. Tonsillar B cells isolated from children with negative selection were pre-incubated with MoAb against CD19 or CD21. Thereafter, biotin-conjugated MID was added and binding analysed by flow cytometry. As shown in Fig. 5 , pre-incubation with anti-CD19 MoAb (Serotec) or anti-CD21 MoAb did not inhibit the binding of MID to tonsillar B cells isolated from children. Moreover, another anti-CD19 antibody (rabbit-anti-human CD19-RPE from DAKO) was tested for the ability to block the binding of MID, which also showed a similar result (data not shown). We are currently investigating the binding of MID to different human IgD þ CD19 þ B-cell lines. Preliminary results obtained by flow cytometry analysis reveal that the presence of CD21 is crucial for MID binding to IgD þ CD19 þ B cells. B-cell lines that express IgD and CD19, but lack or express very low levels of CD21, bound the MID protein to a lesser extent compared to cells that express IgD, CD19 and moderate or high levels of CD21. As the anti-CD21 MoAb used in our study was unable to inhibit MID-induced proliferation as well as binding, it might be speculated that the CD21-binding epitope of this MoAb does not interfere with the MID-binding epitope of CD21. Whether or not MIDmediated signalling through CD19 is dependent on CD21 needs to be further evaluated.
For the membrane-bound BCR, Iga (CD79a) and Igb (CD79b) play essential roles in the signal transduction through the immunoreceptor tyrosine-based activation motifs (ITAMs) located in their intracytoplasmic region. It is thought that signals transduced by IgM or IgD receptors on B cells are the same but with different kinetics [22] . The affinity threshold required for IgM signalling is decreased when antigen-C3d complexes colligate the BCR and CD19/CD21 complex [1] . It is obvious that CD19 signalling complements or modulates the regulatory signals of other receptors, particularly the BCR. However, the signalling capability of CD19 is not dependent on the expression of surface immunoglobulin, as CD19 ligation can provide proliferative signals for surface IgM -precursor B cells [23] . CD21 is physically associated with CD19 on the surface of human B cells, but the CD19 complex does not require CD21 for signal transduction. After the isolation of B cells using anti-CD19-conjugated beads, not only the CD19 molecule, but also the CD21 molecule is occupied for anti-CD21 antibody staining (our own observation). CD21 binds to the complement fragments iC3b, C3d and/or C3dg, which can function as opsonins and stimulate phagocytosis or, in the case of B cells, act as a link between costimulatory receptors and the BCR.
Moraxella catarrhalis has now been recognized as an important pathogen in respiratory tract infections in both children and adults [14, 15] . M. catarrhalis is the third most common bacterial agent in acute otitis media in children and often implicated as a cause of sinusitis in both children and adults. The search for potential vaccine antigens is an important task, as more than 90% of M. catarrhalis clinical isolates are resistant to penicillin. It is therefore of great importance to study the interactions between IgD and IgD-binding proteins, especially in children. Young children have a higher vulnerability to infections mainly due to immaturity of the immune system, but one of the main problems in infant immunity is the inability to mount an adequate and rapid response to thymus-independent type 2 (TI-2) antigens (partly dependent on T-cell help) [24, 25] . It has been shown that children under 2 years of age lack the expression of CD21 on marginal zone B cells in the spleen [25] . In our study, tonsillar B cells from children aged between 2 and 6 years expressed similar amounts of CD21 as compared with tonsillar B cells from adults (data not shown). Moreover, the addition of anti-CD21 MoAb to negatively selected MID-stimulated B cells from children only have a minor effect on the proliferation, whereas anti-CD19 MoAb strongly inhibited the proliferative response. The complement receptor 1 (or CD35) is also expressed on human B cells and binds C3b fragments. CD21 and CD35 might be physically associated on the surface. Most interestingly, Jozsi et al. [26] have shown that CD35 mediates inhibitory signals in tonsillar B cells from children. The role of the molecule in B-cell activation is controversial, probably due to different experimental conditions, the use of mixed cell populations and antibodies that react with various epitopes of CD35. Whether CD35 also has a role in IgD-mediated signalling in tonsillar B cells of children will be further investigated in our laboratory.
In conclusion, the bacterial outer membrane protein MID binds with strong affinity to human IgD, but requires the CD19 molecule either alone or in complex with CD21 for the induction of optimal activation of tonsillar B cells. Importantly, tonsillar B cells from children seem to have a strong requirement for the costimulatory CD19-signalling pathway when stimulated with MID.
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